Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Merck Shows Takeover Interest In Seagen: WSJ

  • Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the matter.
  • If the deal happens, it would be significant, given Seagen's market value of roughly $28 billion.
  • According to the report, some people said other unnamed suitors are also eying Seagen, a perennially speculated takeover target.
  • Also Read: Amid Domestic Violence Allegation, Longtime Seagen CEO Takes Leave of Absence.
  • Talks have been underway for a while, the people said.
  • Though the people cautioned that pulling off the deal could be tricky given the heightened risk of a regulatory challenge. 
  • WSJ also mentioned that a marketing agreement is also possible between Merck and Seagen.
  • Related: Read Why This Analyst Is 'Encouraged' By Seagen's Q1 Sales.
  • Price Action: SGEN shares are up 13.30% at $166.26, and MRK stock is up 0.06% at $84.94 during the market session on the last check Friday.
  • Photo via Pixabay
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.